Male Dysuria with Normal Urinalysis
In a male patient with dysuria and completely normal urinalysis (no leukocytes, nitrites, or blood), the most appropriate next step is to perform a digital rectal examination to assess the prostate, obtain a 3-day frequency-volume chart, and evaluate for non-infectious causes including prostatitis, benign prostatic hyperplasia, or urethritis from sexually transmitted infections. 1
Immediate Diagnostic Steps
Physical Examination
- Perform a digital rectal examination (DRE) to assess prostate size, consistency, tenderness, and symmetry—this distinguishes benign prostatic hyperplasia from prostatitis and excludes locally advanced prostate cancer. 1, 2
- Examine the suprapubic area for bladder distention and inspect external genitalia for lesions or discharge. 1, 2
- A tender prostate on DRE suggests prostatitis, while an enlarged, non-tender prostate points toward BPH-related symptoms. 1
Symptom Characterization
- Complete the International Prostate Symptom Score (IPSS) questionnaire to quantify severity: 0-7 mild, 8-19 moderate, 20-35 severe. 1, 2
- Obtain a 3-day frequency-volume chart documenting time and volume of each void, especially when nocturia is prominent (≥2 episodes per night). 1, 2
- Assess sexual history and risk factors for sexually transmitted infections, particularly in men under 35 years. 1
Age-Stratified Differential Diagnosis
Younger Men (<35 years)
- Urethritis from sexually transmitted infections is the most common cause in this age group. 1
- Perform nucleic acid amplification testing (NAAT) on first-void urine or urethral swabs for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma species. 3
- Consider non-gonococcal urethritis even with negative initial testing if sexual exposure history is present. 1
Older Men (≥50 years)
- Benign prostatic hyperplasia is the most common cause of lower urinary tract symptoms including dysuria in this population. 1, 2
- Chronic prostatitis (bacterial or non-bacterial) should be considered, particularly if perineal pain or ejaculatory discomfort accompanies dysuria. 3
- Offer serum PSA measurement to men with ≥10-year life expectancy where knowledge of prostate cancer would change management. 4, 2
Critical Pitfall: The Normal Urinalysis
A completely normal urinalysis does NOT rule out significant urologic pathology. 1 The absence of pyuria, nitrites, and hematuria makes bacterial cystitis extremely unlikely but does not exclude:
- Prostatitis (chronic bacterial or chronic pelvic pain syndrome)—the Meares-Stamey 4-glass test or simplified 2-glass test is required to localize infection to the prostate. 3
- Urethritis—first-void urine NAAT is more sensitive than urinalysis for detecting STI-related urethritis. 3
- Early BPH—irritative symptoms can occur before significant obstruction develops. 1, 2
- Bladder outlet obstruction—measure post-void residual (PVR) by ultrasound; PVR >100-200 mL is clinically significant. 1
When to Refer to Urology IMMEDIATELY
Refer before initiating any treatment if any of the following are present: 1, 2
- Neurological disease affecting bladder function
- Palpable bladder or suspected urinary retention
- Abnormal DRE findings suspicious for prostate cancer (nodules, asymmetry, induration)
- Hematuria (even if microscopic)
- Recurrent urinary tract infections (≥2 in 6 months or ≥3 in 12 months)
- Severe obstruction on uroflowmetry (Qmax <10 mL/second)
Initial Management for Non-Urgent Cases
Lifestyle Modifications (First-Line for All Patients)
- Target approximately 1 liter of urine output per 24 hours—excessive fluid intake worsens symptoms in older men without providing benefit when no infection is present. 1
- Reduce fluid intake in the evening to minimize nocturia. 1, 2
- Avoid bladder irritants including alcohol, caffeine, and highly seasoned foods. 1
- Encourage physical activity and avoid prolonged sedentary periods. 1
Pharmacologic Therapy (If Symptoms Persist After 2-4 Weeks)
- Alpha-blocker monotherapy (e.g., tamsulosin 0.4 mg daily) is first-line for moderate-to-severe symptoms (IPSS 8-35) and provides relief within 2-4 weeks. 1
- Assess treatment effectiveness at 2-4 weeks for alpha-blockers. 1, 2
- For men with large prostates (>30-40 grams by DRE or imaging), consider adding a 5α-reductase inhibitor, but effectiveness requires 3-6 months to assess. 1, 2
Special Diagnostic Considerations
If Prostatitis is Suspected
- Never perform prostatic massage in suspected acute bacterial prostatitis—this risks precipitating bacteremia and sepsis. 3
- For chronic prostatitis, the Meares-Stamey 4-glass test (or simplified 2-glass variant) is the gold standard, demonstrating a 10-fold higher bacterial count in expressed prostatic secretions versus midstream urine. 3
- Obtain blood cultures and complete blood count if systemic symptoms (fever, chills, hypotension) suggest bacteremia. 3
If Urethritis is Suspected
- First-void urine NAAT is superior to urethral swab for patient comfort and has equivalent sensitivity. 3
- Treat empirically for gonorrhea and chlamydia while awaiting results if high clinical suspicion exists. 1
Follow-Up Strategy
- If vague symptoms persist or worsen over 2-4 weeks despite lifestyle modifications, schedule follow-up to discuss formal evaluation for BPH-related symptoms using IPSS and consider prostate-specific treatments. 1
- For patients on watchful waiting, perform annual evaluation with repeat symptom score, DRE, and urinalysis. 2
- For patients on medical therapy, reassess at treatment-specific intervals using IPSS and assessment of bother. 2
What NOT to Do
- Do not prescribe empiric antibiotics—with a normal urinalysis, there is no evidence of infection and antibiotics provide no benefit while contributing to antimicrobial resistance. 1, 5
- Do not assume all dysuria in men represents urinary tract infection—the differential is broad and age-dependent. 1, 2
- Do not order routine cystoscopy or upper-tract imaging without specific indications (hematuria, recurrent infections, stones, renal insufficiency)—these have low diagnostic yield in uncomplicated cases. 1, 2
- Do not initiate anticholinergic agents without first confirming acceptable PVR—these drugs can precipitate urinary retention in patients with elevated residual volumes. 1